Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

Y0001288

Salbutamolsulfat für die Systemeignung

European Pharmacopoeia (EP) Reference Standard

Synonym(e):

Salbutamol -hemisulfat (Salz), α1-[(tert.-Butylamino)-methyl]-4-hydroxy-1,3-benzoldimethanol -hemisulfat (Salz), Albuterolsulfat

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C13H21NO3 · 0.5H2SO4
CAS-Nummer:
51022-70-9
Molekulargewicht:
288.35
MDL-Nummer:
MFCD00055200
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329831344
NACRES:
NA.24

Qualität

pharmaceutical primary standard

API-Familie

albuterol, salbutamol

Hersteller/Markenname

EDQM

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

Lagertemp.

−20°C

SMILES String

OS(O)(=O)=O.CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.CC(C)(C)NCC(O)c2ccc(O)c(CO)c2

InChI

1S/2C13H21NO3.H2O4S/c2*1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;1-5(2,3)4/h2*4-6,12,14-17H,7-8H2,1-3H3;(H2,1,2,3,4)

InChIKey

BNPSSFBOAGDEEL-UHFFFAOYSA-N

Angaben zum Gen

human ... ADRB2(154)

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Salbutamol sulfate for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Verpackung

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Sonstige Hinweise

Sales restrictions may apply.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

PHR1053

Albuterolsulfat, Pharmaceutical Secondary Standard; Certified Reference Material

S0150000

Salbutamolsulfat, European Pharmacopoeia (EP) Reference Standard

Y0000034

Salbutamol Unreinheit G, European Pharmacopoeia (EP) Reference Standard

Y0000030

Salbutamol Unreinheit B, European Pharmacopoeia (EP) Reference Standard

Y0000031

Salbutamol Unreinheit F, European Pharmacopoeia (EP) Reference Standard

Y0000071

Salbutamol Unreinheit D, European Pharmacopoeia (EP) Reference Standard

Y0000032

Salbutamol Unreinheit I, European Pharmacopoeia (EP) Reference Standard

S0100000

Salbutamol, European Pharmacopoeia (EP) Reference Standard

Y0001186

Salbutamol Unreinheit J, European Pharmacopoeia (EP) Reference Standard

1012633

Albuterolsulfat, United States Pharmacopeia (USP) Reference Standard

1358784

Levalbuterol -hydrochlorid, United States Pharmacopeia (USP) Reference Standard

1012600

Albuterol, United States Pharmacopeia (USP) Reference Standard

1012644

Albuterol-verwandte Verbindung A, United States Pharmacopeia (USP) Reference Standard

1012655

Albuterol-verwandte Verbindung B, United States Pharmacopeia (USP) Reference Standard

1012689

Albuterol-verwandte Verbindung E, United States Pharmacopeia (USP) Reference Standard

BP451

Salbutamol, British Pharmacopoeia (BP) Reference Standard

BP302

Salbutamol-Sulfat, British Pharmacopoeia (BP) Reference Standard

PHR1960

Salbutamol-Unreinheit D, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2040

Albuterol-verwandte Verbindung B, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1961

Salbutamol-Unreinheit G, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1962

Salbutamol-Unreinheit I, Pharmaceutical Secondary Standard; Certified Reference Material

BP712

Salbutamol-Aldehyd-Unreinheit, British Pharmacopoeia (BP) Reference Standard

BP192

2-tert-Butylamino-1-(4-Hydroxy-3-methylphenyl)ethanolsulfat, British Pharmacopoeia (BP) Reference Standard

BP852

Salbutamol-Unreinheit B, British Pharmacopoeia (BP) Reference Standard

BP704

Salbutamol-Keton-Unreinheit, British Pharmacopoeia (BP) Reference Standard

PHR2106

4-[2-[(1,1-Dimethylethyl)amino]ethyl]-2-methylphenol, Pharmaceutical Secondary Standard; Certified Reference Material

PHR9050

4-[2-(tert.-Butylamino)-1-methoxyethyl]-2-(hydroxymethyl)-phenol, reference material, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

PHR9071

4-[2-[Benzyl-(tert.-butyl)-amino]-1-hydroxyethyl]-2-(hydroxymethyl)-phenol, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

1012564

Albuterol Related Compound I, United States Pharmacopeia (USP) Reference Standard

PHR2332

Methyl5-[2-[benzyl(tert-butyl)amino]acetyl]-2-hydroxybenzoate hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

Piktogramme

Health hazardExclamation mark
GHS08,GHS07

Signalwort

Warning

Gefahreneinstufungen

Carc. 2 - Repr. 2 - Skin Sens. 1

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 2

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Choose from one of the most recent versions:

Analysenzertifikate (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 1

1 of 1

Salbutamol

Sigma-Aldrich

S8260

Salbutamol

B Padhukasahasram et al.
The pharmacogenomics journal, 14(4), 365-371 (2014-01-15)
Inhaled short-acting beta-agonist (SABA) medication is commonly used in asthma patients to rapidly reverse airway obstruction and improve acute symptoms. We performed a genome-wide association study of SABA medication response using gene-based association tests. A linear mixed model approach was
Todd A Florin et al.
JAMA pediatrics, 168(7), 664-670 (2014-05-28)
Acute bronchiolitis is the most frequent lower respiratory tract infection in infants, yet there are no effective therapies available. Current evidence is unclear about the role of hypertonic saline (HS) for the acute treatment of bronchiolitis. To determine whether nebulized
Dwight D Koeberl et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 28(5), 2171-2176 (2014-01-21)
Effective dosages for enzyme replacement therapy (ERT) in Pompe disease are much higher than for other lysosomal storage disorders, which has been attributed to low cation-independent mannose-6-phosphate receptor (CI-MPR) in skeletal muscle. We have previously demonstrated the benefit of increased
Helgo Magnussen et al.
The New England journal of medicine, 371(14), 1285-1294 (2014-09-10)
Treatment with inhaled glucocorticoids in combination with long-acting bronchodilators is recommended in patients with frequent exacerbations of severe chronic obstructive pulmonary disease (COPD). However, the benefit of inhaled glucocorticoids in addition to two long-acting bronchodilators has not been fully explored.
Tianwen Lai et al.
BMC pulmonary medicine, 15, 1-1 (2015-01-13)
YKL-40 is also called chitinase-3-like-1 (CHI3L1) protein and may be a marker for asthma. The aims of the present study were to investigate whether serum YKL-40 levels are stable or decreased in patients with asthma after appropriate treatment and to
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.